Acinar Cell Carcinoma of the Pancreas
Differential Diagnosis
- Ductal adenocarcinoma
- Pancreatic endocrine tumor
- Solid-pseudopapillary neoplasm
- Pancreatoblastoma
- Serous microcystic adenoma
- Serous oligocystic adenoma
- Acinar cell cystadenoma
- Medullary carcinoma
| Acinar Cell Carcinoma of the Pancreas | Ductal Adenocarcinoma of the Pancreas |
|---|---|
| Granular cytoplasm | Mucinous cytoplasm |
| Nuclei round, usually basal, at most moderately pleomorphic | Pleomorphic nuclei, may be variably located |
| Usually solid or acinar formations | Large, irregular open ductal formations |
| Lobular pattern without desmoplastic stroma | Desmoplastic stroma |
| Single, large, central nucleoli | Nucleoli variable |
| BCL10, trypsin, chymotrypsin positive | BCL10, trypsin, chymotrypsin negative |
| Acinar Cell Carcinoma of the Pancreas | Well Differentiated Pancreatic Neuroendocrine (Islet Cell) Tumor |
|---|---|
| Granular PASd+ cytoplasm | PASd negative |
| Basal nuclear polarization | Centrally located nuclei |
| Vesicular nuclei with prominent nucleoli | Salt and pepper stippled chromatin |
| BCL10, trypsin, chymotrypsin positive | BCL10, trypsin, chymotrypsin negative |
| Synaptophysin and chromogranin positivity <25% in pure tumors, mixed tumors may have more | Synaptophysin or chromogranin positivity widespread, over 25% |
| Acinar Cell Carcinoma of the Pancreas | Poorly Differentiated Pancreatic Neuroendocrine (Islet Cell) Tumor |
|---|---|
| Granular PASd+ cytoplasm | PASd negative |
| BCL10, trypsin, chymotrypsin positive | BCL10, trypsin, chymotrypsin negative |
| Stromal fibrosis rare | Frequent fibrotic stroma |
| Synaptophysin and chromogranin positivity <25% in pure tumors, mixed tumors may have more | Synaptophysin or chromogranin positivity widespread, over 25% |
| Acinar Cell Carcinoma of the Pancreas | Solid Pseudopapillary Neoplasm of the Pancreas |
|---|---|
| Predominantly male | Overwhelmingly female |
| Granular PASd+ cytoplasm | PASd+ only scattered globules |
| Beta-catenin/CD56/CD10 negative | Beta-catenin/CD56/CD10 positive |
| BCL10, trypsin, chymotrypsin positive | BCL10, trypsin, chymotrypsin negative |
| Alpha 1 antitrypsin negative | Alpha 1 antitrypsin positive |
| Keratin positive | Keratin variable |
| Usually infiltrative | Usually circumscribed |
| Lacks pseudopapillary architecture | Frequent pseudopapillary architecture |
| May have true lumens | No true lumens |
| Frequently increased mitotic figures | Infrequent mitotic figures |
| CD99 negative | CD99 paranuclear dots (one report) |
| Acinar Cell Carcinoma of the Pancreas | Pancreatoblastoma |
|---|---|
| Typically older patients (40-70 years), rare in children | 2/3 <5 years, adult cases mean age 40 |
| Lacks squamoid nests | Squamoid nests present |
| Serous Microcystic Adenoma | Acinar Cell Cystadenocarcinoma of the Pancreas |
|---|---|
| Lined by clear cells | Lined by cells with granular eosinophilic cytoplasm |
| Frequent central scar | Lacks central scar |
| PAS+, diastase sensitive | PAS+, diastase resistant |
| BCL10, trypsin, chymotrypsin negative | BCL10, trypsin, chymotrypsin positive |
| Serous Macrocystic / Oligocystic Adenoma | Acinar Cell Cystadenocarcinoma of the Pancreas |
|---|---|
| Lined by clear cells | Lined by cells with granular eosinophilic cytoplasm |
| PAS+, diastase sensitive | PAS+, diastase resistant |
| BCL10, trypsin, chymotrypsin negative | BCL10, trypsin, chymotrypsin positive |
| Acinar Cell Cystadenoma of the Pancreas | Acinar Cell Cystadenocarcinoma of the Pancreas |
|---|---|
| Cytologically bland | Cytologically moderately atypical with prominent nucleoli |
| Mitotic figures absent to very rare | Mitotic figures frequent |
| No infiltration | Frequently infiltrative |
| Medullary Carcinoma of the Pancreas | Poorly Differentiated Acinar Carcinoma of the Pancreas |
|---|---|
| Pleomorphic nuclei with variable nucleoli | Prominent central nucleoli in most cases |
| Lipase and trypsin negative | Lipase and trypsin positive in most cases |
| May show microsatellite instability and/or mismatch repair deficiency | No mismatch repair defects |

